Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

Tae Geun Gweon, Yoo Jin Lee, Kyeong Ok Kim, Sung Kyun Yim, Jae Seung Soh, Seung Young Kim, Jae Jun Park, Seung Yong Shin, Tae Hee Lee, Chang Hwan Choi, Young Seok Cho, Dongeun Yong, Jin Won Chung, Kwang Jae Lee, Oh Young Lee, Myung Gyu Choi, Miyoung Choi

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions.

Original languageEnglish
Pages (from-to)28-42
Number of pages15
JournalJournal of Neurogastroenterology and Motility
Issue number1
Publication statusPublished - 2022 Jan

Bibliographical note

Funding Information:
Financial support: This research was supported by a grant of

Publisher Copyright:
© 2022 The Korean Society of Neurogastroenterology and Motility

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Gastroenterology


Dive into the research topics of 'Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea'. Together they form a unique fingerprint.

Cite this